Log In
Print this Print this

Olumiant, baricitinib (LY3009104) (formerly INCB28050)

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionJanus kinase-1 (JAK-1) and JAK-2 inhibitor
Molecular Target Janus kinase-2 (JAK-2) ; Janus kinase-1 (JAK-1)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor; Janus kinase-1 (JAK-1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today